TRADING_as_a_BUSINESS

Metacrine Inc πŸ§™

Pembelian
NASDAQ:MTCR   None
Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. Its FXR product candidates include MET409 and MET642.

If you want more trading ideas like this one ,🎯 press a thumb up! πŸ‘ Have a question? Don't be shy to ask! πŸ€“ Interested to study how to analyze charts, follow me!

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.